Correlation Between Cardio Diagnostics and Sonnet Biotherapeutics

Can any of the company-specific risk be diversified away by investing in both Cardio Diagnostics and Sonnet Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cardio Diagnostics and Sonnet Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cardio Diagnostics Holdings and Sonnet Biotherapeutics Holdings, you can compare the effects of market volatilities on Cardio Diagnostics and Sonnet Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cardio Diagnostics with a short position of Sonnet Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cardio Diagnostics and Sonnet Biotherapeutics.

Diversification Opportunities for Cardio Diagnostics and Sonnet Biotherapeutics

-0.17

Correlation Coefficient

Cardio Diagnostics  Sonnet Biotherapeutics

Good diversification

The 3 months correlation between Cardio and Sonnet is -0.17. Overlapping area represents the amount of risk that can be diversified away by holding Cardio Diagnostics Holdings and Sonnet Biotherapeutics Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sonnet Biotherapeutics and Cardio Diagnostics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cardio Diagnostics Holdings are associated (or correlated) with Sonnet Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sonnet Biotherapeutics has no effect on the direction of Cardio Diagnostics i.e., Cardio Diagnostics and Sonnet Biotherapeutics go up and down completely randomly.

Pair Corralation between Cardio Diagnostics and Sonnet Biotherapeutics

Given the investment horizon of 90 days Cardio Diagnostics Holdings is expected to under-perform the Sonnet Biotherapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Cardio Diagnostics Holdings is 3.78 times less risky than Sonnet Biotherapeutics. The stock trades about -0.16 of its potential returns per unit of risk. The Sonnet Biotherapeutics Holdings is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest  132.00  in Sonnet Biotherapeutics Holdings on May 6, 2025 and sell it today you would earn a total of  147.00  from holding Sonnet Biotherapeutics Holdings or generate 111.36% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Cardio Diagnostics Holdings  vs.  Sonnet Biotherapeutics Holding

Cardio Diagnostics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Cardio Diagnostics Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's forward indicators remain very healthy which may send shares a bit higher in September 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Sonnet Biotherapeutics

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Sonnet Biotherapeutics Holdings are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Sonnet Biotherapeutics displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Cardio Diagnostics and Sonnet Biotherapeutics

The main advantage of trading using opposite Cardio Diagnostics and Sonnet Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cardio Diagnostics position performs unexpectedly, Sonnet Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sonnet Biotherapeutics will offset losses from the drop in Sonnet Biotherapeutics' long position.

The idea behind Cardio Diagnostics Holdings and Sonnet Biotherapeutics Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.